Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
TNXPthis companyTonix Pharmaceuticals Holding Corp.	$4.47	-1.07×	0.54×	10.14×	0.6×	373.2%	34.7%	-959.1%	-946.2%	-50.6%	-51.0%	-77.6%	0.01×	1.69×	-1,412.39×	7.42×	0.0%	3	-4.63	3	B
AVTXAvalo Therapeutics, Inc.	$7.04	-3.11×	2.93×	4,125.96×	-2.96×	-86.5%	100.0%	-123601.7%	-132642.4%	-94.2%	-70.2%	-21.1%	0.03×	0.17×	0×	8.14×	0.0%	2	4.43	2	B-
ELDNEledon Pharmaceuticals, Inc.	$2.77	-2.7×	1.52×	0×	-2.24×	-91.0%	0.0%	0.0%	0.0%	-56.3%	-55.1%	-50.4%	0.01×	0.49×	0×	7.4×	0.0%	1	-4.22	2	C
ELTXElicio Therapeutics, Inc.	$1.63	-3.09×	74.5×	0×	-3.16×	-85.8%	0.0%	0.0%	0.0%	-2418.8%	-201.0%	-30.3%	8.87×	0.11×	-33.29×	2.38×	0.0%	2	-14.29	1	D+
FATEFate Therapeutics, Inc.	$1.93	-0.85×	0.56×	17.56×	-1.16×	-121.9%	-94.1%	-2222.4%	-2051.1%	-65.8%	-51.4%	-96.0%	0.38×	-0.25×	0×	5.79×	0.0%	3	-8.27	1	C-
MCRBSeres Therapeutics, Inc.	$2.00	23.25×	2.98×	167.07×	17.2×	-266.7%	-423.8%	-11910.1%	721.9%	12.9%	-72.7%	0.7%	1.88×	3.78×	0×	2.56×	0.0%	3	-14.74	1	C-
Peer median	—	-2.7×	2.93×	17.56×	-2.24×	-91.0%	0.0%	-2222.4%	0.0%	-65.8%	-70.2%	-30.3%	0.38×	0.17×	0×	5.79×	0.0%	2	-8.27	1	—